Cargando…
Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
[Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab f...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155210/ https://www.ncbi.nlm.nih.gov/pubmed/37040431 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081 |
_version_ | 1785036285093609472 |
---|---|
author | Zhang, Cheng Bye, Jordan W. Lui, Lok H. Zhang, Hongyu Hales, John Brocchini, Steve Curtis, Robin A. Dalby, Paul A. |
author_facet | Zhang, Cheng Bye, Jordan W. Lui, Lok H. Zhang, Hongyu Hales, John Brocchini, Steve Curtis, Robin A. Dalby, Paul A. |
author_sort | Zhang, Cheng |
collection | PubMed |
description | [Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab fragment A33 as the model protein. Aggregation kinetics were determined for 0.05 to 100 mg/mL Fab A33, at 65 °C. A surprising trend was observed whereby increasing the concentration decreased the relative aggregation rate, ln(v) (% day(–1)), from 8.5 at 0.05 mg/mL to 4.4 at 100 mg/mL. The absolute aggregation rate (mol L(–1) h(–1)) increased with the concentration following a rate order of approximately 1 up to a concentration of 25 mg/mL. Above this concentration, there was a transition to an apparently negative rate order of −1.1 up to 100 mg/mL. Several potential mechanisms were examined as possible explanations. A greater apparent conformational stability at 100 mg/mL was observed from an increase in the thermal transition midpoint (T(m)) by 7–9 °C, relative to those at 1–4 mg/mL. The associated change in unfolding entropy (△S(vh)) also increased by 14–18% at 25–100 mg/mL, relative to those at 1–4 mg/mL, indicating reduced conformational flexibility in the native ensemble. Addition of Tween or the crowding agents Ficoll and dextran, showed that neither surface adsorption, diffusion limitations nor simple volume crowding affected the aggregation rate. Fitting of kinetic data to a wide range of mechanistic models implied a reversible two-state conformational switch mechanism from aggregation-prone monomers (N*) into non-aggregating native forms (N) at higher concentrations. k(D) measurements from DLS data also suggested a weak self-attraction while remaining colloidally stable, consistent with macromolecular self-crowding within weakly associated reversible oligomers. Such a model is also consistent with compaction of the native ensemble observed through changes in T(m) and △S(vh). |
format | Online Article Text |
id | pubmed-10155210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101552102023-05-04 Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations Zhang, Cheng Bye, Jordan W. Lui, Lok H. Zhang, Hongyu Hales, John Brocchini, Steve Curtis, Robin A. Dalby, Paul A. Mol Pharm [Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab fragment A33 as the model protein. Aggregation kinetics were determined for 0.05 to 100 mg/mL Fab A33, at 65 °C. A surprising trend was observed whereby increasing the concentration decreased the relative aggregation rate, ln(v) (% day(–1)), from 8.5 at 0.05 mg/mL to 4.4 at 100 mg/mL. The absolute aggregation rate (mol L(–1) h(–1)) increased with the concentration following a rate order of approximately 1 up to a concentration of 25 mg/mL. Above this concentration, there was a transition to an apparently negative rate order of −1.1 up to 100 mg/mL. Several potential mechanisms were examined as possible explanations. A greater apparent conformational stability at 100 mg/mL was observed from an increase in the thermal transition midpoint (T(m)) by 7–9 °C, relative to those at 1–4 mg/mL. The associated change in unfolding entropy (△S(vh)) also increased by 14–18% at 25–100 mg/mL, relative to those at 1–4 mg/mL, indicating reduced conformational flexibility in the native ensemble. Addition of Tween or the crowding agents Ficoll and dextran, showed that neither surface adsorption, diffusion limitations nor simple volume crowding affected the aggregation rate. Fitting of kinetic data to a wide range of mechanistic models implied a reversible two-state conformational switch mechanism from aggregation-prone monomers (N*) into non-aggregating native forms (N) at higher concentrations. k(D) measurements from DLS data also suggested a weak self-attraction while remaining colloidally stable, consistent with macromolecular self-crowding within weakly associated reversible oligomers. Such a model is also consistent with compaction of the native ensemble observed through changes in T(m) and △S(vh). American Chemical Society 2023-04-11 /pmc/articles/PMC10155210/ /pubmed/37040431 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Zhang, Cheng Bye, Jordan W. Lui, Lok H. Zhang, Hongyu Hales, John Brocchini, Steve Curtis, Robin A. Dalby, Paul A. Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations |
title | Enhanced
Thermal Stability and Reduced Aggregation
in an Antibody Fab Fragment at Elevated Concentrations |
title_full | Enhanced
Thermal Stability and Reduced Aggregation
in an Antibody Fab Fragment at Elevated Concentrations |
title_fullStr | Enhanced
Thermal Stability and Reduced Aggregation
in an Antibody Fab Fragment at Elevated Concentrations |
title_full_unstemmed | Enhanced
Thermal Stability and Reduced Aggregation
in an Antibody Fab Fragment at Elevated Concentrations |
title_short | Enhanced
Thermal Stability and Reduced Aggregation
in an Antibody Fab Fragment at Elevated Concentrations |
title_sort | enhanced
thermal stability and reduced aggregation
in an antibody fab fragment at elevated concentrations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155210/ https://www.ncbi.nlm.nih.gov/pubmed/37040431 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081 |
work_keys_str_mv | AT zhangcheng enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT byejordanw enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT luilokh enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT zhanghongyu enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT halesjohn enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT brocchinisteve enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT curtisrobina enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations AT dalbypaula enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations |